A comparison of interferon-γ and IP-10 for the diagnosis of tuberculosis

Line Lindebo Holm1, Michala Vaaben Rose2, Godfather Kimaro3

  • 1Clinical Research Centre, and Departments of Paediatrics and line.lindebo.holm@gmail.com.

Pediatrics
|November 26, 2014
PubMed

Insights

Interferon-γ (IP-10) and QuantiFERON-TB Gold In-tube (QFT-IT) assays showed poor accuracy for diagnosing active tuberculosis in Tanzanian children. Performance was compromised in young children, making them unsuitable for this population in high-burden settings.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pediatric Medicine

Background:

  • Tuberculosis (TB) diagnosis in children remains challenging, particularly in high-burden settings.
  • Interferon-γ (IFN-γ) release assays, including IP-10 and QuantiFERON-TB Gold In-tube (QFT-IT), are used to detect TB infection.
  • Evaluating the diagnostic accuracy of these tests in pediatric populations is crucial.

Purpose of the Study:

  • To compare the diagnostic accuracy of IP-10 and QFT-IT assays for active tuberculosis in hospitalized Tanzanian children.
  • To assess the impact of age and other factors on test performance in children.

Main Methods:

  • A comparative diagnostic accuracy study was conducted in hospitalized Tanzanian children suspected of active TB.
  • Children were tested using both IP-10 and QFT-IT assays.
  • Adults with confirmed TB were assessed in parallel for comparison.

Main Results:

  • The study included 203 children, with a median age of 3.0 years; 38% were HIV-infected, and 36% were under 2 years old.
  • Both IP-10 and QFT-IT showed low sensitivity in children (33% and 29% for confirmed/probable TB, respectively) but comparable performance in adults (80%).
  • High rates of indeterminate results were observed (29% for IP-10, 26% for QFT-IT), particularly in children under 2 years.

Conclusions:

  • IP-10 and QFT-IT assays demonstrated poor performance in diagnosing active TB in hospitalized Tanzanian children.
  • Test accuracy was significantly compromised in younger children (<2 years) and associated with high indeterminate rates.
  • These IFN-γ release assays cannot be recommended for diagnosing active TB in hospitalized children in TB-endemic regions.
Abstract

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
768
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
47
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.6K